ArticleClinical pharmacology in drug development2021

Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control Study.

Joanna C Masters et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.